Lexaria Bioscience (LEXX) Interest & Investment Income (2023 - 2026)
Lexaria Bioscience's (LEXX) quarterly Interest & Investment Income came in at $1769.0 in Q1 2026, up 14641.67% quarter-over-quarter from $12.0 in Q4 2025.
Lexaria Bioscience (LEXX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Interest & Investment Income across 4 years of filings, most recently posting $1769.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1769.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was $4787.0 (down 31.65% YoY), and the FY2025 annual result was $3017.0, down 78.92% from the prior year.
- Interest & Investment Income came in at $1769.0 for Q1 2026 at Lexaria Bioscience, up from $12.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $7319.0 in Q4 2023 to a low of -$1.0 in Q1 2024.
- The 4-year median for Interest & Investment Income is $979.5 (2025), against an average of $2388.6.
- Across the five-year window, Interest & Investment Income plunged 99.85% in 2024 and gained 9.09% in 2025, its largest moves.
- Lexaria Bioscience's Interest & Investment Income stood at $7319.0 in 2023, then slumped by 99.85% to $11.0 in 2024, then climbed by 9.09% to $12.0 in 2025, then surged by 14641.67% to $1769.0 in 2026.
- The last three Interest & Investment Income figures came in at $1769.0 (Q1 2026), $12.0 (Q4 2025), and $2816.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 | 1,769.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1,769.00 |
| Nov 30, 2025 | 12.00 |
| Aug 31, 2025 | 2,816.00 |
| May 31, 2025 | 190.00 |
| Nov 30, 2024 | 11.00 |
| Aug 31, 2024 | 6,993.00 |
| Feb 29, 2024 | -1.00 |
| Nov 30, 2023 | 7,319.00 |